R. Bril

发表

Tumor‐derived microparticles induce bone marrow‐derived cell mobilization and tumor homing: A process regulated by osteopontin

T. Voloshin, V. Miller, Y. Shaked, 2014, International journal of cancer.

Host response to short-term, single-agent chemotherapy induces matrix metalloproteinase-9 expression and accelerates metastasis in mice.

T. Voloshin, Y. Shaked, F. Bertolini, 2011, Cancer research.

Dequalinium blocks macrophage-induced metastasis following local radiation.

V. Miller, Y. Shaked, S. Rotenberg, 2015, Oncotarget.

Tumor‐Initiating Cells of Various Tumor Types Exhibit Differential Angiogenic Properties and React Differently to Antiangiogenic Drugs

T. Voloshin, Y. Shaked, S. Scherer, 2012, Stem cells.

Porfimer-sodium (Photofrin-II) in combination with ionizing radiation inhibits tumor-initiating cell proliferation and improves glioblastoma treatment efficacy

Y. Shaked, R. Satchi‐Fainaro, M. Schaffer, 2013, Cancer biology & therapy.

Anti-Bv8 Antibody and Metronomic Gemcitabine Improve Pancreatic Adenocarcinoma Treatment Outcome Following Weekly Gemcitabine Therapy12

T. Voloshin, Y. Shaked, A. Karban, 2014, Neoplasia.

G-CSF supplementation with chemotherapy can promote revascularization and subsequent tumor regrowth: prevention by a CXCR4 antagonist.

T. Voloshin, R. Kerbel, Y. Shaked, 2011, Blood.

Differential Therapeutic Effects of Anti–VEGF-A Antibody in Different Tumor Models: Implications for Choosing Appropriate Tumor Models for Drug Testing

T. Voloshin, V. Miller, Y. Shaked, 2013, Molecular Cancer Therapeutics.

Differential Therapeutic Effects of Anti–VEGF-A Antibody in Different Tumor Models: Implications for Choosing Appropriate Tumor Models for Drug Testing

T. Voloshin, V. Miller, Y. Shaked, 2013, Molecular Cancer Therapeutics.